Prime Medicine Inc (PRME)

EBITDA Growth

20.51%

Quarterly · Period ending:

PRME logo

PRME EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported20.51%
PRME Quarterly EBITDA YoY % (-18.51% → 20.51%)
High-resolution chart · PNG

PRME ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Prime Medicine Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
20.5078%
5.8259%
-8.9844%
4.4329%
5.927%
-13.265%
23.8986%
-1.4654%
-30.7668%
-14.9558%
-38.0761%
-76.1813%
-40.4496%
-60.0856%
37.0337%
-53.1399%
-1,113.8122%
-359.6984%
-2,281.5462%
-18.5083%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.